TULIP: Translating Unique Learning for Incontinence Prevention

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT01599715
Collaborator
National Institute of Nursing Research (NINR) (NIH)
647
2
2
52
323.5
6.2

Study Details

Study Description

Brief Summary

More than one in three US women suffers from the distressing, embarrassing, and often unreported problem of urinary incontinence (UI). UI severity increases with age and the financial cost exceeds $19 billion per year . The Adult Conservative Management Committee of the 2008 International Consultation on Incontinence concluded that pelvic floor muscle training (PFMT) should be offered as first line therapy to all women with stress, urge, or mixed UI; and that bladder training (BT) may be preferred to drug therapy. Conservative strategies are low risk and differ from other forms of UI management in that they do not prejudice future treatments. They also may decrease symptoms of urgency and frequency that do not entail UI, but greatly reduce the quality of life for nearly 1 in 11 US women.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Instructional DVD
  • Behavioral: Bladder Health Class
Phase 2

Detailed Description

The study will attempt to accomplish 3 aims:

Aim 1: Compare outcomes of the two-hour BH Class with the condensed DVD version.

To accomplish this aim we will conduct a comparative effectiveness trial of 600 women 55 years and older randomized to BH Class or DVD. Women will be followed for 24 months post-intervention in order to assess long-term outcomes and sustainability.

Aim 2: Conduct an economic analysis comparing the two-hour BH Class with the DVD version. Describing the costs, quality of life, and analyzing the willingness to pay and employment/ productivity data will be the primary economic focus of this study.

Aim 3: Conduct a qualitative analysis to gain insight into elements of the intervention that contribute to sustainability.

Inclusion/Exclusion Criteria

Inclusion:
  1. Female, aged 55 years or older

  2. An additive sum of the frequency (question 1) and volume (question 2) items from the International Consultation on Incontinence Questionnaire-Short Form is ≤5

  3. Negative for demonstrable UI on the standardized Paper Towel Test

  4. Willing to undergo vaginal/pelvic examination

  5. Willing and able to be compliant with visit schedule and study procedures for the study duration

  6. Provide written informed consent form

  7. Able to understand and read English

Exclusion:
  1. Non-ambulatory (patient confined to bed or wheelchair)

  2. Persistent pelvic pain (defined as daily pelvic pain)

  3. History of neurologic diseases (e.g. Cerebral Vasular Accident, Parkinson's disease, Multiple sclerosis, Epilepsy, Spinal cord tumor or trauma, spina bifida, current symptomatic herniated disc)

  4. Actively taking UI, OAB, or any other bladder control medication.

  5. Other urinary conditions or procedures that may affect continence status (e.g. history of bladder cancer, urethral diverticula, previous augmentation cystoplasty or artificial sphincter; implanted nerve stimulators for urinary symptoms, history of sling surgery for UI or prolapse)

  6. Participation in another research project that may influence the results of this trial

  7. Pelvic organ prolapse protruding past the introitus upon straining

  8. Absolute absence of pelvic floor muscle strength manifested by zero Brink test (Brink et al., 1994 for pressure and displacement 9

  9. Evidence of UTI or hematuria - Urine dipstick positive for red blood cells will exclude the participant from enrollment in the study until a microscopic urinalysis is negative. Urine dipstick positive for leukocytes plus nitrates will exclude the participant from enrollment in the study and require further evaluation for UTI.

  10. History of > 2 recurrent UTI's in the past year and no more than one UTI within 6 months

  11. Post void residual > 150 cc

Study Design

Study Type:
Interventional
Actual Enrollment :
647 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Investigator)
Primary Purpose:
Prevention
Official Title:
Translating Unique Learning for Incontinence Prevention for Women Over the Age of 55
Study Start Date :
Sep 1, 2010
Actual Primary Completion Date :
Jan 1, 2015
Actual Study Completion Date :
Jan 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Other: Instructional DVD Intervention

Participants randomized to this arm watched an eighteen minute bladder health instructional DVD at the conclusion of a successful baseline screening visit. This intervention occurred only once

Behavioral: Instructional DVD
Participants randomized to this arm watched an eighteen minute bladder health instructional DVD at the conclusion of a successful baseline screening visit. This intervention occurred only once.

Other: Bladder Health Class Intervention

Participants randomized to this arm attended a two-hour bladder health instruction session that reviewed 3 primary self-care techniques that have been proven to prevent or lessen the severity of urinary incontinence. This session occurred only once 1-3 weeks subsequent to a successful baseline screening visit.

Behavioral: Bladder Health Class
Participants randomized to this arm attended a two-hour bladder health instruction session that reviewed 3 primary self-care techniques that have been proven to prevent or lessen the severity of urinary incontinence. This session occurred only once 1-3 weeks subsequent to a successful baseline screening visit.

Outcome Measures

Primary Outcome Measures

  1. Translating Unique Learning for Incontinence Prevention (TULIP) [5 years]

    Prevention study for Urinary Incontinence in women over the age of 55 who are fully continent (do not leak urine at all) or mildly continent (leak small drops of urine on occasion). This study will measure the effectiveness of 2 interventions: a bladder health instruction session or Bladder Health DVD administration.

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Female, aged 55 years or older

  2. An additive sum of the frequency (question 1) and volume (question 2) items from the International Consultation on Incontinence Questionnaire-Short Form is ≤5

  3. Negative for demonstrable UI on the standardized Paper Towel Test

  4. Willing to undergo vaginal/pelvic examination

  5. Willing and able to be compliant with visit schedule and study procedures for the study duration

  6. Provide written informed consent form

  7. Able to understand and read English

Exclusion Criteria:
  1. Non-ambulatory (patient confined to bed or wheelchair)

  2. Persistent pelvic pain (defined as daily pelvic pain)

  3. History of neurologic diseases (e.g. Cerebral Vasular Accident, Parkinson's disease, Multiple sclerosis, Epilepsy, Spinal cord tumor or trauma, spina bifida, current symptomatic herniated disc)

  4. Actively taking UI, OAB, or any other bladder control medication.

  5. Other urinary conditions or procedures that may affect continence status (e.g. history of bladder cancer, urethral diverticula, previous augmentation cystoplasty or artificial sphincter; implanted nerve stimulators for urinary symptoms, history of sling surgery for UI or prolapse)

  6. Participation in another research project that may influence the results of this trial

  7. Pelvic organ prolapse protruding past the introitus upon straining

  8. Absolute absence of pelvic floor muscle strength manifested by zero Brink test (Brink et al., 1994 for pressure and displacement 9

  9. Evidence of UTI or hematuria - Urine dipstick positive for red blood cells will exclude the participant from enrollment in the study until a microscopic urinalysis is negative. Urine dipstick positive for leukocytes plus nitrates will exclude the participant from enrollment in the study and require further evaluation for UTI.

  10. History of > 2 recurrent UTI's in the past year and no more than one UTI within 6 months

  11. Post void residual > 150 cc

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan School of Nursing Ann Arbor Michigan United States 48109
2 University of Pennsylvania Department of Urology Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • University of Michigan
  • National Institute of Nursing Research (NINR)

Investigators

  • Principal Investigator: Carolyn Sampselle, PHD, RN, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Carolyn Sampselle, Carolyne K Davis Professor of Nursing, University of Michigan
ClinicalTrials.gov Identifier:
NCT01599715
Other Study ID Numbers:
  • The TULIP Project
  • R01NR012011-01
First Posted:
May 16, 2012
Last Update Posted:
May 12, 2016
Last Verified:
May 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by Carolyn Sampselle, Carolyne K Davis Professor of Nursing, University of Michigan
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 12, 2016